Europe

Stéphane Bancel, the CEO of the pharmaceutical company Moderna, warned on Thursday that a COVID-19 vaccine is not "a silver bullet," to end the pandemic, and advised people to continue wearing masks and follow public health guidelines.

Country / Region Tags:

Europe

Germany

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Moderna CEO Cautions That COVID Vaccine Is 'Not a Silver Bullet' to End Pandemic
Log in or register to post comments

Pfizer, BioNTech formally seek emergency use of COVID-19 shots in US

Fri, 2020-11-20 17:20 — mike kraft

Pfizer, BioNTech seek emergency use of COVID-19 shots in US Pfizer formally asked U.S. regulators Friday to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and... AP NEWS

Pfizer formally asked U.S. regulators Friday to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic -- but not until after a long, hard winter.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Pfizer, BioNTech formally seek emergency use of COVID-19 shots in US
Log in or register to post comments

COVID-19 reinfection unlikely for at least 6 months, study finds

Fri, 2020-11-20 12:15 — mike kraft

COVID-19 reinfection unlikely for at least 6 months, study finds People who've had COVID-19 are highly unlikely to contract it again for at least six months after their first infection, according to a British study of healthcare workers on the frontline of fight against the coronavirus pandemic. The findings should offer some reassurance for the more than 51 million people worldwide who have been infected with the pandemic disease, researchers at the University of Oxford said.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about COVID-19 reinfection unlikely for at least 6 months, study finds
Log in or register to post comments

Southern Europe rues exodus of doctors, nurses as coronavirus surges

Fri, 2020-11-20 11:32 — mike kraft

Southern Europe rues exodus of doctors, nurses as coronavirus surges Thirty-year-old Pep Iglesies emigrated to Canada from Spain in August for a new job that is much like his old one – taking care of coronavirus patients and working as a cardiologist. Joan Faus, Angelo Amante U.S.

BARCELONA/ROME (Reuters) - Thirty-year-old Pep Iglesies emigrated to Canada from Spain in August for a new job that is much like his old one – taking care of coronavirus patients and working as a cardiologist.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Southern Europe rues exodus of doctors, nurses as coronavirus surges
Log in or register to post comments

AP roundup: U.S. official expects quick vaccine distribution, International developments

Fri, 2020-11-20 10:18 — mike kraft

The Latest: U.S. official expects quick vaccine distribution WASHINGTON — Gen. Gustave Perna of the Trump administration’s Operation Warp Speed vaccine program says about 40 million doses could be ready for distribution in the U.S. quickly if the Food and... AP NEWS

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about AP roundup: U.S. official expects quick vaccine distribution, International developments
Log in or register to post comments

Roundup: International Deverlopoments on spread of the coronavirus -_Reuters

Thu, 2020-11-19 10:56 — mike kraft

Factbox; Latest on worldwide spread of the coronavirus AstraZeneca and Oxford University's potential COVID-19 vaccine produced a strong immune response in older adults, data published on Thursday showed, with researchers expecting to release late-stage trial results by Christmas. Reuters Staff U.S.

(Reuters) - AstraZeneca and Oxford University’s potential COVID-19 vaccine produced a strong immune response in older adults, data published on Thursday showed, with researchers expecting to release late-stage trial results by Christmas.

Country / Region Tags:

General Topic Tags: